Travere Therapeutics, Inc. · NASDAQ:TVTX
Dube Eric M sold 64,000 Travere Therapeutics, Inc. shares (Form 4)
Traded Apr 13 to Apr 15, 2026 · Filed Apr 15, 2026
From Apr 13 to Apr 15, 2026, Dube Eric M (Director, CHIEF EXECUTIVE OFFICER) sold 64,000 Travere Therapeutics, Inc. shares at an average US$41.09 for US$2.63M under a trading plan, leaving 432,886 shares. Filed Apr 15, 2026 (Form 4).
- Sold
- 64,000 shares
- Price
- US$41.09 average (US$41.01 to US$42.66)
- Value
- US$2.63M
- Holding after
- 432,886 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director, CHIEF EXECUTIVE OFFICER
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Apr 13, 2026 | Common Stock | Award | 64,000 | 496,886 | Direct | |
| Apr 15, 2026 | Common Stock | Sale | 56,815 | US$41.01 | 440,071 | Direct |
| Apr 15, 2026 | Common Stock | Sale | 7,165 | US$41.75 | 432,906 | Direct |
| Apr 15, 2026 | Common Stock | Sale | 20 | US$42.66 | 432,886 | Direct |
Source
Related
- Travere Therapeutics, Inc.
- Dube Eric M
- Travere Therapeutics, Inc. shareholders
- Form 4 · Dube Eric M · Oct 19, 2026
- Form 4 · Dube Eric M · Sep 17, 2026
- Form 4 · Dube Eric M · May 6, 2026
- Form 4 · Dube Eric M · Apr 2, 2026
- Form 4 · Heerma Peter · Sep 17, 2026
- Form 4 · Rote William E. · Sep 17, 2026
- Form 4 · Inrig Jula · Sep 17, 2026
- Schedule 13G/A · Armistice Capital, LLC · Aug 14, 2026
- Schedule 13G · Bank of America Corp · Aug 12, 2026